ライフサイエンスコーパス: female sex

1 ed with an increased risk of CP were age and female sex.

2 omy use, number of stents, hypertension, and female sex.

3 recurrent ACS over 12 months, independent of female sex.

4 c hospital resources, late presentation, and female sex.

5 renal disease (ESRD) patients, especially of female sex.

6 decrease in VSF; 95% CI, -0.66 to -0.43) and female sex (-0.25 logit decrease in VSF; 95% CI, -0.45 t

7 ; >/=80 years: 7.57 [5.71-10.04], P < .001), female sex (1.10 [1.01-1.20], P = .047), nonwhite race/e

8 +/- 16, and 73 +/- 14 years, respectively), female sex (18%, 27%, and 39%, respectively), symptoms (

9 edictors (all shown as OR [95% CI]) included female sex (2.27 [1.14-4.50]), younger age (0.83 [.74-.9

10 .8 years at the time of the index diagnosis; female sex, 52%) received a diagnosis of QAV between Jan

11 r thickness (1.08 [1.01, 1.16] per mum), and female sex (6.57 [1.25, 48.79]).

12 l group and the nonsurgical group, including female sex (65.5% vs 64.2%), median age (52.5 vs 54.8 ye

13 Although we know that female sex, a history of childhood maltreatment, and fam

14 Female sex (adjusted odds ratio [OR] 0.69; 95% CI, 0.59-

15 Female sex (adjusted odds ratio, 1.61; 95% CI, 1.16-2.22

16 In multivariable logistic regression, female sex (adjusted odds ratio, 3.83; 95% confidence in

17 n in pts with initially successful CA for AF female sex, AF type, in-hospital AF relapse and comorbid

18 was afforded by vaccination, younger age, or female sex against 2017-2018 circulating H3N2 viruses.

19 derivation cohort included the variables of female sex, age of 13 years or older, physician-diagnose

20 idence interval: 1.117 to 2.407; p = 0.012), female sex, age, diabetes, smoking, heart failure, previ

21 ssociated with lower deportation chance were female sex, ages 0-5 or 15-30 years, and being immigrant

22 .2, a mean CHADS2VASC (CHADS2 in addition to female sex, ages 65-75, as well as double impact of age

23 9 studies identified an association between female sex and a greater willingness to undergo bariatri

24 Female sex and a history of arthritis were identified as

25 In pCIS, female sex and a multifocal onset were risk factors for

26 The multivariate analysis revealed female sex and AF type prior to the procedure as predict

27 Female sex and age >75 years were also independently ass

28 Besides age, female sex and APOE epsilon4 genotype represent strong r

29 Female sex and black race were associated with higher an

30 D4, higher HIV-1 RNA, no injection drug use, female sex and black race.

31 6K PD mutation to investigate the effects of female sex and brain-selective estrogen treatment on alp

32 rge cohort of patients with TTR amyloidosis, female sex and decreased VA were associated with ocular

33 Independent predictors of complications were female sex and device infections.

34 Recent studies have focused on the role of female sex and estradiol (E2) in pulmonary arterial hype

35 aring the major genetic risk factors for MS (female sex and HLA risk haplotypes).

36 On multivariate analysis, female sex and initial therapeutic response to medicatio

37 outcomes identified patient factors, such as female sex and low education, associated with worse reco

38 nhanced platelet activation correlating with female sex and microvascular and oxidative damages.

39 Risk factors for thromboembolic events were female sex and middle cerebral artery location.

40 Female sex and receipt of antibiotics during the hospita

41 (18)F-Fluorodeoxyglucose uptake, as well as female sex and renal function.

42 f the literature regarding the influences of female sex and reproductive hormones (primarily estradio

43 Female sex and shockable rhythms were associated with hi

44 parathyroid autotransplantation, higher age, female sex and surgery at a low volume center.

45 For DP, female sex and the absence of neoadjuvant therapy predic

46 There were no interactions between female sex and the following variables: age, type of loc

47 Female sex and the presence of both risk alleles of CFH-

48 high nevus count, low risk for melanoma, and female sex) and 1 melanoma-related factor (in situ melan

49 Higher initial tTGA titers, female sex, and a history of hypothyroidism and autoimmu

50 levels of school attainment and resilience, female sex, and absence of parental divorce.

51 dings show a strong association between age, female sex, and an APOE4 genotype, with decreased cortic

52 igher HIV type 1 RNA, no injection drug use, female sex, and black race.

53 In the multivariate model, age, female sex, and cardiovascular disease were associated w

54 Risk factors for recurrence were older age, female sex, and comorbidity.

55 le prognosis was associated with opsoclonus, female sex, and diagnosis before 12 months of age, where

56 After adjustment, older age, female sex, and donation after implementation of new cen

57 eyes of patients aged younger than 60 years, female sex, and eyes implanted with an IOL of <22.5 diop

58 ptor antagonists at presentation, older age, female sex, and history of heart failure.

59 Age 18-40 years, female sex, and human immunodeficiency virus coinfection

60 verse outcome were younger age at diagnosis, female sex, and increased left atrial dimension.

61 t chemotherapy, intraoperative heated chemo, female sex, and length of stay shorter than 14 days.

62 analysis, baseline CD4 count <350 cells/mm3, female sex, and lower baseline HBV deoxyribonucleic acid

63 EMW, heart rate-corrected QT interval (QTc), female sex, and LQTS genotype as univariate predictors o

64 Younger age, female sex, and more advanced comorbidity were associate

65 ssion included remote history of depression, female sex, and more symptomatic angina based on Canadia

66 nt in North America (versus Western Europe), female sex, and older age were associated with greater l

67 increasing age, clinical stage III disease, female sex, and the presence of medical comorbidities (a

68 d with a poor prognosis, whereas opsoclonus, female sex, and younger age at diagnosis were associated

69 race/ethnicity (aOR 3.3; 95% CI, 2.3, 4.7), female sex (aOR 2.0; 95% CI, 1.4, 2.9), age >/= 35 years

70 variable analyses, HIV (aOR, 0.44; P < .01), female sex (aOR, 0.08; P = .03), physical activity level

71 Both history of early-life stress (ELS) and female sex are associated with increased risk for depres

72 Younger age and female sex are both associated with greater mental stres

73 alth Stroke Scale at admission, hemineglect, female sex, atrial fibrillation, and no history of strok

74 ssues, adolescent-onset allergic disease and female sex; (b) Psychological factors-asthma and food al

75 iate analysis indicated that use of the BVS, female sex, balloon-artery ratio >1.25, expansion index

76 or resection were age younger than 50 years, female sex, being married, higher tumor grade, and prese

77 fidence interval [CI]: 0.05, 0.46; P = .01), female sex (beta coefficient, 0.51; 95% CI: 0.15, 0.88;

78 hormones as drivers of sex differences, that female sex bias in MC-associated diseases is evident in

79 ors were nonmodifiable and included age <60, female sex, black race, higher comorbidity burden, previ

80 6-month unplanned readmissions included age, female sex, black/Hispanic race, prior amputation, Charl

81 Mean age was 57 years, 25% female sex, BMI was 28, CHA2DS2-VASc score was 0 to 1 in

82 with baseline characteristics that included female sex, body mass index >/=35, fasting glucose >5.5

83 Female sex, body mass index >50 kg/m, type 2 diabetes, h

84 ecies are gonochoristic (i.e., have male and female sexes), but self-fertile hermaphroditic species a

85 Female sex, cardiovascular disease, higher body mass ind

86 ic background (i.e., lacking the ancestral W female sex chromosome), and is hemizygous.

87 stem by targeting sequences exclusive to the female sex chromosome.

88 Female sex, chronic kidney disease, enrollment date, and

89 aseline clinical characteristics (older age, female sex, chronic obstructive pulmonary disease; P<0.0

90 ic regression analysis included younger age, female sex, comorbid angina, chronic obstructive pulmona

91 rceration included: age older than 40 years, female sex, current smoker, body mass index 30 or greate

92 associated symptoms with increasing age and female sex; detection of respiratory syncytial virus (RS

93 o is enhanced by expression of the canonical female sex determinant Dsx(F), indicating that chinmo ac

94 ent with this finding, ectopic expression of female sex determinants in the adult testis disrupts tis

95 We demonstrate that the female sex determination gene, Sex-lethal (Sxl), functio

96 in the transformer gene (Bdtra) required for female sex determination.

97 offspring reveals the B chromosome carries a female sex determiner that is epistatically dominant to

98 that the Wolbachia insert is now acting as a female sex-determining region in pillbugs, and that the

99 hood of referral included older patient age, female sex, diabetes-related ESKD, higher comorbid disea

100 er of antiepileptic drugs before withdrawal, female sex, family history of epilepsy, number of seizur

101 the success of genets through their male and female sex functions.

102 cal features of AF-TR included advanced age, female sex, greater right atrial than left atrial enlarg

103 d middle-income countries, were age <1 year, female sex, >=3 days of illness prior to presentation to

104 ore, only prior stroke, age >/=75 years, and female sex had a stronger association with incident stro

105 Female sex had an inverse relationship with PHE growth,

106 R is the opposite of that in SAVR, for which female sex has been shown to be independently associated

107 Risk factors for allograft steatosis were female sex (hazard ratio [HR], 1.47; 95% confidence inte

108 Risk factors for reflux recurrence included female sex (hazard ratio [HR], 1.57 [95% CI, 1.29-1.90];

109 d ratio, 1.67; 95% CI, 1.24-2.24; P < .001), female sex (hazard ratio, 1.34; 95% CI, 1.03-1.73; P = .

110 ine ADAU was negatively associated with age, female sex, height, and body mass index, and these varia

111 ntly associated with the outcome: older age, female sex, higher baseline serum creatinine value, albu

112 erse changes included hypertension, obesity, female sex, Hispanic and non-Hispanic black ethnicity, w

113 res associated with risk included older age, female sex, history of smoking, history of hypertension,

114 st and SMC markers, expression of VEGF-D and female sex hormone receptors, reduced autophagy, and met

115 for RANK in lung cancer and may explain why female sex hormones accelerate lung cancer development.

116 model of anaphylaxis and explore the role of female sex hormones and the mechanisms responsible.

117 There is evidence implicating the role of female sex hormones as a major factor in determining mig

118 tween male and female mice, and we show that female sex hormones can promote lung cancer progression

119 Female sex hormones have been hypothesized to play a rol

120 there remains uncertainty about the role of female sex hormones in the development of asthma.

121 riectomized mice, we highlighted the role of female sex hormones in the phenotype.

122 as to assess mechanisms behind the impact of female sex hormones on host immune responses to P. aerug

123 Because actions of female sex hormones on normal renal tissue might protect

124 indicate a predominantly negative effect of female sex hormones on oral immunity with role in the ae

125 tations throughout the body, mediated by the female sex hormones progesterone and estrogen.

126 smoking, epidemiological studies have linked female sex hormones to lung cancer in women; however, th

127 t differentiation receptor RANK(4,5) couples female sex hormones to the rewiring of the thymus during

128 et during reproductive years have implicated female sex hormones, particularly 17-beta estradiol (E2)

129 e lung IL2Cs, uterine ILC2s are regulated by female sex hormones, which may specialize them for speci

130 aling and also was related to the effects of female sex hormones.

131 l hazard model showed that risk factors were female sex (HR 2.52, 95% CI 1.04-6.10), history of smoki

132 1 to 60 years (HR = 1.22, 95% CI 1.03-1.44), female sex (HR = 1.5; 95% CI 1.3-1.74), white ethnicity

133 s age <45 years] = 1.79; 95% CI, 1.03-3.11), female sex (HR = 1.61; 95% CI, 1.04-2.49), and Hispanic

134 education (HR, 0.67; 95% CI, 0.54-0.85) and female sex (HR, 0.65; 95% CI, 0.52-0.80) were associated

135 31 to 1.45]) versus a single-chamber device, female sex (HR, 1.16 [CI, 1.12 to 1.21]), and black race

136 Female sex, hypertension, carotid artery stenosis, aorti

137 Female sex, hypertension, diabetes mellitus, higher body

138 Most animals have male and female sexes, implying that sex is ancient and beneficia

139 Uptake was positively associated with female sex in the index patient (adjusted odds ratio [aO

140 , vascular disease, aged 65 to 74 years, and female sex) increased from 0/1 to 6+ points, the inciden

141 ABSTRACT: Female sex is a risk factor for inherited and acquired l

142 s well as vascular and stroke complications, female sex is an independent predictor of late survival

143 Female sex is an independent risk factor for death or st

144 Female sex is associated with poorer outcomes after surg

145 for 1-year outcome have been observed: age, female sex, lactate value, Model of End-Stage Liver Dise

146 ion with ulcer or gangrene, age >/=65 years, female sex, large hospital size, teaching hospital statu

147 nd presents negative relationships with age, female sex, left ventricular ejection fraction, and body

148 Age <65 years, female sex, low family income, lack of health insurance,

149 stolic pulmonary artery pressure, older age, female sex, lower ejection fraction, mitral regurgitatio

150 Older age, female sex, lower socioeconomic status, diabetes, system

151 DMRT1 expression in the ovary silenced the female sex-maintenance gene Foxl2 and reprogrammed juven

152 focused on XX hermaphrodites, an essentially female sex making sperm in larvae and oocytes in adults.

153 On univariate and multivariate analyses, female sex (men to women risk of readmission odds ratio

154 reasing DSN, donors were increasingly older, female sex, mismatched gender (female donor with a male

155 al disorder was associated with younger age, female sex, more recent admitting years, presence of pre

156 associated with increased risk of HCV, while female sex, more years injecting, more injections in the

157 g waitlisted individuals included older age, female sex, more years on dialysis before waitlisting, t

158 Female sex, multiple comorbidities, concomitant therapy

159 ent r: 0.40) with the systemic parameters of female sex (nonstandardized regression coefficient B: 0.

160 macular ChT was associated with younger age, female sex, nonwhite ethnicities, and myopia (P <= .013)

161 cularization, hypertension, unstable angina, female sex, nonwhite race, and US location were associat

162 ors of receiving a transplant were dialysis, female sex, nonwhite race, high albumin, and creatinine.

163 olbachia insert shows perfect linkage to the female sex, occurs in a male genetic background (i.e., l

164 Female sex (odds ratio [OR] range, 1.82-2.22), inpatient

165 s associated with thromboembolic events were female sex (odds ratio [OR], 1.7; 95% confidence interva

166 ratio, 4.06; 95% CI, 3.87-4.23; p < 0.001), female sex (odds ratio, 1.17; 95% CI, 1.14-1.20; p < 0.0

167 Female sex (odds ratio, 2.2; 95% confidence interval, 1.

168 Independent risk factors for death included female sex (odds ratio, 2.6; P = .04), and age >=45 year

169 Female sex of child, shorter duration of exclusive breas

170 /flu or pneumonia within the past two years, female sex, older age, a history of COPD (positive LC-as

171 Persons of white race, female sex, older age, and lower BMI were at increased r

172 ssociations were found between awareness and female sex, older age, being married rather than being s

173 Female sex, older age, viral load, and late-stage diseas

174 ing clinical evidence as to the influence of female sex on outcomes after transcatheter aortic valve

175 d demonstrate that the beneficial effects of female sex on PD-like neuropathology can be reinstated b

176 However, the effects of female sex or estrogen on alpha-synuclein (alphaS) homeo

177 , age above 60 year (OR 1.64; 1.36-1.98) and female sex (OR 1.27; 1.05-1.54).

178 Female sex (OR 2.3, 95% CI 1.5 to 3.7), smoking (2.1, 1.

179 ty of life (VRQOL) (odds ratio [OR] = 2.41), female sex (OR = 1.42), younger age (OR per 10 years you

180 fidence interval [CI], .94-.99; P < .01) and female sex (OR, 0.35; 95% CI, .14-.75; P < .01) were les

181 , 1.03; 95% CI, 1.01-1.04; P < .01), whereas female sex (OR, 0.46; 95% CI, .33-.66; P < .01) and hist

182 ement to bed (OR: 0.49; 95% CI: 0.44, 0.55), female sex (OR: 0.53; 95% CI: 0.5, 0.56), younger age (O

183 ed to GORD was significantly associated with female sex [OR - 0.436 (95% CI 0.342-0.555)], being boar

184 Female sex [OR: 1.79 (1.05-3.05)] and younger age repres

185 factors in questionnaires were older age and female sex ( P < .01).

186 ade hemorrhage was more likely to occur with female sex (P = .001), older age (P = .003), emphysema (

187 The proportion of female sex (P = .009), kidney dysfunction (P = .001), ca

188 (P = .001), G6PD deficiency (P = <.001), and female sex (P = .034) correlated with higher counts.

189 ophil engraftment (p < 0.001; p = 0.021) and female sex (p = 0.023; p = 0.038) as independent predict

190 igher baseline NMS score was associated with female sex (p=0.008), higher baseline MDS-UPDRS Part II

191 le urinary tract infections (UTIs) and their female sex partners, 6 strains (all UTI causing) were sh

192 ners and inversely associated with number of female sex partners.

193 f Drosophila melanogaster by deletion of the female sex peptide receptor.

194 impose selection pressure on the long-range female sex pheromone channel and consequently affect the

195 evices to selectively detect the presence of female sex pheromone of olive fruit fly before the onset

196 ces for selective and sensitive detection of female sex pheromone of olive fruit pest, Bactocera olea

197 In moths, more long-range female sex pheromones have been identified than in any o

198 ors using volatile semiochemicals that mimic female sex pheromones.

199 Independent predictors for SVCs were female sex, pre-operative New York Heart Association fun

200 Older age, female sex, preference for English, more education, heal

201 ore and glucose on admission, and more often female sex, prior stroke, and prior functional dependenc

202 Our findings suggest that female sex protects against systemic inflammation-induce

203 Female sex, public insurance, medical comorbidities, lon

204 subsets; 95% CI, 0.705-0.746): younger age; female sex; racial or ethnic minority; no history of hyp

205 Our data suggest an ancient female sex ratio bias that predates the loss of adults,

206 The male-female sex ratio was 1.17.

207 Eighty patients (male/female sex ratio, 0.95; mean +/- SD age, 47.3 +/- 18.3 y

208 ne attacks occurring in 37 patients (male-to-female sex ratio, 1.05; mean +/- SD age, 51 +/- 11.4 yr)

209 .1 [95% confidence interval {CI}, 1.3-3.5]), female sex (reference, male sex; aOR, 1.8 [95% CI, 1.1-2

210 multivariable logistic regression analysis, female sex remained independently associated with risk o

211 oth volumetric responders and nonresponders, female sex remained strongly associated with a lower ris

212 d syndrome, craniosynostosis with XY male-to-female sex reversal or CSR.

213 ryos by RNA interference resulted in male to female sex reversal, characterized by obvious feminizati

214 h range from hypospadias to complete male-to-female sex reversal.

215 s; 95% confidence interval (CI) 3.35, 4.75], female sex (RR 1.32; 95% CI 1.14, 1.54), and lower body

216 stroke, vascular disease, age 65 to 74, and female sex) score might improve stroke prediction in pat

217 the reference population included older age, female sex, single cohabitation status, basic educationa

218 Conversely, female sex, small duct, soft gland, minimally invasive a

219 Predictors of symptoms included young age, female sex, smoking, and experiencing symptoms before RY

220 ological comorbidity, acute gastroenteritis, female sex, smoking, use of non-steroidal anti-inflammat

221 This article uses a case scenario to examine female sex-specific cardiovascular risk factors across t

222 of reproductive organs was restricted to the female sex, suggesting input from the sex determination

223 Female sex tended to associate with a diagnosis of micro

224 preprocedural analgesia was associated with female sex, term birth, high illness severity, tracheal

225 In multivariable analysis, younger age, female sex, thickness of 0.76 mm or larger, increasing C

226 Younger age, female sex, unemployment, alcohol misuse, and greater op

227 sociated with migraine with aura, young age, female sex, use of oral contraceptives and smoking habit

228 Female sex was also a significant risk factor (P = 0.03)

229 Female sex was also associated with a lower risk of LTD

230 Female sex was an independent predictor of in-hospital m

231 By multivariable analysis, female sex was an independent predictor of MACE (hazard

232 On multivariable analyses, female sex was an independent predictor of mortality (od

233 cation density, and aortic annulus diameter, female sex was an independent risk factor for higher fib

234 ter, tumor pathology, and vascular invasion, female sex was associated with a 25% lower risk of post-

235 After risk adjustment, female sex was associated with a 48% increase in 30-day

236 Female sex was associated with a lower risk of cardiovas

237 After adjusting for >20 risk factors, female sex was associated with a significant risk of dea

238 Female sex was associated with a significantly increased

239 Female sex was associated with all and uncomplicated eve

240 Female sex was associated with greater diary-questionnai

241 After multivariable analyses, female sex was associated with LV end-systolic volume ch

242 ith white race (HR, 2.05; P < .001), whereas female sex was associated with reduced risk (HR, 0.74; P

243 and meta-analysis of observational studies, female sex was found to be a significant risk factor for

244 A competing risk analysis demonstrated that female sex was independently associated with a 10% (conf

245 Female sex was independently associated with increased p

246 Female sex was not an independent predictor of mortality

247 s (32.8% vs. 24.7%; log-rank p = 0.002), but female sex was not an independent predictor of mortality

248 Female sex was not associated with LT overall, but a sig

249 Female sex was not associated with outcomes post-ACS.

250 Female sex was predominant in the group with gingival ca

251 In contrast, female sex was significantly protective for time to deat

252 Female sex was the strongest predictor of tongue cleanin

253 tivariable analysis, low FGF19, low CIT, and female sex were associated with chronic cholestasis.

254 tive patients, vaccination, younger age, and female sex were associated with greater nAb responses to

255 group were SAH, trimethylamine, choline, and female sex, whereas plasma phosphatidylcholine was a neg

256 is was associated with higher ATX and MCP-1, female sex with higher ATX and IL-6, older age with high

257 tional cohorts of Fisherfolk (2012-2014) and Female sex workers (2014-2017).

258 with men (MSM), injecting drug users (IDU), female sex workers (FSW) and heterosexuals (HET) in coas

259 girls-and-young-women (aged 15-24; AGYW) and female sex workers (FSW), and (ii) availability for ever

260 HIV transmission in the general population, female sex workers (FSW), and men who have sex with men

261 Syphilis prevalence data from female sex workers (FSW), men who have sex with men (MSM

262 In Cameroon, female sex workers (FSWs) and men who have sex with men

263 Project, which offered both interventions to female sex workers (FSWs) at 2 urban clinic sites in Sou

264 Female sex workers (FSWs) bear a disproportionately larg

265 a predictor of HIV epidemic potential among female sex workers (FSWs) globally.

266 The psychological health of female sex workers (FSWs) has emerged as a major public

267 nisms compared to the standard of care among female sex workers (FSWs) in Zambia.

268 ng in schools and workplaces, and testing of female sex workers (FSWs), men who have sex with men (MS

269 -testing may thus be particularly useful for female sex workers (FSWs), who should test frequently bu

270 Female sex workers accounted for a large proportion of n

271 d 4.70 in those aged 20-24 years), and among female sex workers aged 18-24 years in South Africa (13.

272 prevalence in a high-risk cohort of Zambian female sex workers and single mothers conducted from 201

273 Higher-risk populations included female sex workers and their clients, men who have sex w

274 biological testing were conducted with 7259 female sex workers between 2011-2018 across 10 sub-Sahar

275 82 (81%) of 101 female sex workers distributed more than one self-test t

276 n post-partum care, and 41 (14%) of 298 from female sex workers had positive results.

277 messaging service intervention (WHISPER) for female sex workers in Kenya who had the potential to bec

278 nicaland (Zimbabwe), and also declined among female sex workers in Kenya, but not in the highest-risk

279 Female sex workers in low-income and middle-income count

280 Female sex workers in Mombasa, Kenya, completed a monthl

281 of their risk of infection, and to high-risk female sex workers only, are $65 160 (95% credible inter

282 infection averted when providing PrEP to all female sex workers regardless of their risk of infection

283 have a sufficient effect on behaviour among female sex workers to change pregnancy incidence when us

284 erapy is included; however, PrEP for MSM and female sex workers would be included only at much higher

285 natal care, 117 in post-partum care, and 102 female sex workers); follow-up interviews were completed

286 ediate-risk populations, 13.2% (7.2-20.7) in female sex workers, 11.3% (9.0-13.7) in infertility clin

287 aws and stigmas in increasing HIV risk among female sex workers, and examine the mechanisms by which

288 t couples, adolescent girls and young women, female sex workers, and men who have sex with men, inclu

289 vention programs for sex workers, especially female sex workers, are cost-effective in several contex

290 IV transmission in specific key populations (female sex workers, male sex workers, and men who have s

291 gs here essentially pertain to prevalence in female sex workers.

292 ork are associated with HIV prevalence among female sex workers.

293 post-partum clinics and a drop-in centre for female sex workers.

294 106 in post-partum care, and 64 (75%) of 85 female sex workers.

295 n: two in the post-partum care group and two female sex workers.

296 91 from post-partum care, and 53 (83%) of 64 female sex workers.

297 ther men who have sex with men (MSM) or even female sex workers.

298 ciated with increased odds of mortality were female sex, young age, very severe pneumonia, clinically

299 all cost-related nonadherence measures were female sex, younger age, lower income (<$30000), self-re

300 Risk factors include female sex, younger age, psychological distress during o